Platform
A Therapeutic Asset Engine
One integrated approach for turning biological hypotheses into differentiated antibody programs.
Define the Biology
Start with the disease mechanism and the pharmacology a useful therapeutic should produce.
Generate Candidates
Francis creates and prioritizes antibody candidates across formats and molecular properties.
Map Function
Cells-On-Array is being developed to compare candidate behavior in biologically relevant assays.
Advance AssetsRoadmap
Promising molecules move through optimization, lead selection, and preclinical progression.
Evidence guides the next design round
Design · functional data · program decisions
What makes it different
The platform serves the pipeline.
Pharmacology by design
Program design begins with the biological outcome, not a generic request for binding.
Broad candidate exploration
Computational generation supports rapid exploration of antibody candidates and architectures.
Functional evidence
Experimental screening is intended to reveal how molecular choices change biological behavior.
Program ownership
Fabricagen retains the technology, data, and therapeutic assets created by the engine.
Program Building
Capabilities mature.
The objective stays the same.
Move the strongest molecules toward durable therapeutic assets while retaining the learning generated by each program.
Interested in Fabricagen?
We are speaking with investors and select development partners as we advance our internal therapeutic pipeline.
Get in Touch